Attention is being focused on a side effect of Biogen’s Alzheimer’s drug, Aduhelm (aducanumab). Even before its controversial approval on June 7, there were cases of amyloid-related imaging abnormalities (ARIA‑E), or cerebral edema, observed in the trials. [Read more…] about Amyloid-related imaging abnormalities (ARIA) found in approximately 40% of patients taking “Alzheimer’s drug” Aduhelm
In the age of Covid-19, what is the new normal? How many of us have been experiencing the heady cocktail of confusion, anxiety, and even some surprising moments of respite from our recent-past busy rise-and-grind, hustle culture routines?
Our social media feeds are filled with urgent and often conflicting imperatives to change our routines and to direct increased vigilance:
- don’t touch your face, wash our hands-don’t be obsessive though;
- cover our coughs with your elbow-not a tissue;
- social distance-with no interaction, or maybe with some interaction, just watch for your local businesses as you’re sheltering-in; and
- no matter what, don’t panic—you should be scared, but please, stay calm.
–> Keep reading my new article, co-authored with Dr. Karen S. Rommelfanger, over at Emory University’s Neuroethics blog: LESSONS FROM COVID-19: COULD A NEW NORMAL LEAD TO BETTER BRAINS, BODIES, AND SOCIETIES?
Related resources on stress, physical and mental health: